Arm Holdings Is Up 104% and Smart Money Is Waiting for One Specific Level to Buy More

Arm Holdings is viewed as attractive near $223.15, with a preferred accumulation zone around $210 to $215 on pullbacks. The stock has rebounded after a steep first-quarter drawdown, and post-earnings developments have changed the company’s positioning. Arm designs CPU architecture used in most smartphones and now licenses IP while shipping its own silicon for agentic AI data centers. The Arm AGI CPU is described as Arm’s first production data-center chip, with demand exceeding expectations. Customer commitments increased from $1 billion to over $2 billion across FY2027 and FY2028, and data-center royalty revenue more than doubled year over year. Revenue and non-GAAP EPS rose in Q4 FY2026, while valuation remains stretched and margins compressed due to higher R&D spending.

"At $223.15, Arm Holdings screens as attractive to accumulators, with research desks pointing to the $210 to $215 range on any pullback as a favored entry zone. The stock has rebounded sharply from a steep first-quarter drawdown, and the post-earnings story has fundamentally changed what Arm is selling to Wall Street."

"Arm designs the CPU architecture that sits inside nearly every smartphone on Earth, and it now licenses the IP and ships its own silicon into the heart of agentic AI data centers. That second business is the reason shares have surged 104.14% year to date and 33.84% in the last month alone. The launch of the Arm AGI CPU, Arm's first production silicon for the data center, has flipped the narrative from royalty grinder to AI infrastructure principal."

"Customer commitments jumped from $1 billion to over $2 billion across FY2027 and FY2028 in just six weeks, with Meta locked in as lead co-development partner. Hyperscaler CPU share already sits at roughly 50%, with Google replacing x86 in next-gen TPUs using Axion, NVIDIA's Vera CPU launching on Arm, and Microsoft expanding Cobalt across Azure."

"Valuation is the obvious problem. Arm trades at a trailing P/E of 250 and a forward P/E of 98, with a beta of 3.406. Non-GAAP operating margin compressed from 52.8% to 49.1% as R&D spending jumped 43% to $1.91 billion. RPO fell 7% year over year, and pending Qualcomm-Nuvia litigation, SoftBank's controlling stake, and China e"

Read at 24/7 Wall St.